Debiopharm Research & Manufacturing SA – Trademark Portfolio

Entity Type: 99

Debiopharm Research & Manufacturing SA holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include TRELSTAR. The owner is based in Martigny.

Rue du Levant 146

Martigny 1920 , CH

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

TRELSTAR
TRELSTAR
Registered 2020
TRELSTAR
TRELSTAR
Registered 2004
TRELSTAR
TRELSTAR
Registered 2002

Trademark Classifications

Debiopharm Research & Manufacturing SA's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Debiopharm Research & Manufacturing SA have?

Debiopharm Research & Manufacturing SA has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Debiopharm Research & Manufacturing SA file in?

Debiopharm Research & Manufacturing SA files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Debiopharm Research & Manufacturing SA's most well-known trademarks?

Debiopharm Research & Manufacturing SA's registered trademark portfolio includes well-known marks such as TRELSTAR. These are among 3 currently registered trademarks in the portfolio.

What is Debiopharm Research & Manufacturing SA's trademark registration success rate?

Debiopharm Research & Manufacturing SA has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.